246 related articles for article (PubMed ID: 15735852)
1. Hürthle (oncocytic) cell tumors of thyroid: etiopathogenesis, diagnosis and clinical significance.
Sobrinho-Simões M; Máximo V; Castro IV; Fonseca E; Soares P; Garcia-Rostan G; Oliveira MC
Int J Surg Pathol; 2005 Jan; 13(1):29-35. PubMed ID: 15735852
[TBL] [Abstract][Full Text] [Related]
2. Hürthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance.
Máximo V; Sobrinho-Simões M
Virchows Arch; 2000 Aug; 437(2):107-15. PubMed ID: 10993269
[TBL] [Abstract][Full Text] [Related]
3. RET rearrangements in archival oxyphilic thyroid tumors: new insights in tumorigenesis and classification of Hürthle cell carcinomas?
Musholt PB; Imkamp F; von Wasielewski R; Schmid KW; Musholt TJ
Surgery; 2003 Dec; 134(6):881-9; discussion 889. PubMed ID: 14668719
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hürthle cell tumors.
Máximo V; Soares P; Lima J; Cameselle-Teijeiro J; Sobrinho-Simões M
Am J Pathol; 2002 May; 160(5):1857-65. PubMed ID: 12000737
[TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of well-differentiated thyroid carcinomas.
Sobrinho-Simões M; Preto A; Rocha AS; Castro P; Máximo V; Fonseca E; Soares P
Virchows Arch; 2005 Nov; 447(5):787-93. PubMed ID: 16189702
[TBL] [Abstract][Full Text] [Related]
6. Core I gene is overexpressed in Hürthle and non-Hürthle cell microfollicular adenomas and follicular carcinomas of the thyroid.
Máximo V; Preto A; Crespo A; Rocha AS; Machado JC; Soares P; Sobrinho-Simões M
BMC Cancer; 2004 Mar; 4():12. PubMed ID: 15043758
[TBL] [Abstract][Full Text] [Related]
7. Frequent chromosomal DNA unbalance in thyroid oncocytic (Hürthle cell) neoplasms detected by comparative genomic hybridization.
Tallini G; Hsueh A; Liu S; Garcia-Rostan G; Speicher MR; Ward DC
Lab Invest; 1999 May; 79(5):547-55. PubMed ID: 10334566
[TBL] [Abstract][Full Text] [Related]
8. Molecular features of thyroid oncocytic tumors.
Gasparre G; Bonora E; Tallini G; Romeo G
Mol Cell Endocrinol; 2010 May; 321(1):67-76. PubMed ID: 20184940
[TBL] [Abstract][Full Text] [Related]
9. EIF1AX Mutation in a Patient with Hürthle Cell Carcinoma.
Topf MC; Wang ZX; Furlong K; Miller JL; Tuluc M; Pribitkin EA
Endocr Pathol; 2018 Mar; 29(1):27-29. PubMed ID: 28965201
[TBL] [Abstract][Full Text] [Related]
10. Encapsulated papillary oncocytic neoplasms of the thyroid: morphologic, immunohistochemical, and molecular analysis of 18 cases.
Woodford RL; Nikiforov YE; Hunt JL; Bellizzi AM; Zhang X; Mills SE; Stelow EB
Am J Surg Pathol; 2010 Nov; 34(11):1582-90. PubMed ID: 20924280
[TBL] [Abstract][Full Text] [Related]
11. Short Review: Genomic Alterations in Hürthle Cell Carcinoma.
Ganly I; McFadden DG
Thyroid; 2019 Apr; 29(4):471-479. PubMed ID: 30848171
[TBL] [Abstract][Full Text] [Related]
12. Fine-needle aspirations of papillary carcinoma with oncocytic features: an expanded cytologic and histologic profile.
Renshaw AA
Cancer Cytopathol; 2011 Aug; 119(4):247-53. PubMed ID: 21400667
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial DNA "common deletion" in post-fine needle aspiration infarcted oncocytic thyroid tumors.
Conti L; Vatrano S; Bertero L; Masu L; Pacchioni D; Daniele L; De Rosa G; Cassoni P; Volante M; Papotti M
Hum Pathol; 2017 Nov; 69():23-30. PubMed ID: 28962946
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dynamics protein Drp1 is overexpressed in oncocytic thyroid tumors and regulates cancer cell migration.
Ferreira-da-Silva A; Valacca C; Rios E; Pópulo H; Soares P; Sobrinho-Simões M; Scorrano L; Máximo V; Campello S
PLoS One; 2015; 10(3):e0122308. PubMed ID: 25822260
[TBL] [Abstract][Full Text] [Related]
15. My approach to oncocytic tumours of the thyroid.
Asa SL
J Clin Pathol; 2004 Mar; 57(3):225-32. PubMed ID: 14990587
[TBL] [Abstract][Full Text] [Related]
16. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer.
Liska J; Altanerova V; Galbavy S; Stvrtina S; Brtko J
Endocr Regul; 2005 Sep; 39(3):73-83. PubMed ID: 16468229
[TBL] [Abstract][Full Text] [Related]
17. Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.
Máximo V; Botelho T; Capela J; Soares P; Lima J; Taveira A; Amaro T; Barbosa AP; Preto A; Harach HR; Williams D; Sobrinho-Simões M
Br J Cancer; 2005 May; 92(10):1892-8. PubMed ID: 15841082
[TBL] [Abstract][Full Text] [Related]
18. Psammomatous calcifications in thyroid oncocytic (Hürthle cell) follicular tumors.
Ronen N; Suster D
Ann Diagn Pathol; 2023 Feb; 62():152061. PubMed ID: 36459776
[TBL] [Abstract][Full Text] [Related]
19. Benign Hürthle cell adenoma with papillary architecture: a benign lesion mimicking oncocytic papillary carcinoma.
Mai KT; Elmontaser G; Perkins DG; Thomas J; Stinson WA
Int J Surg Pathol; 2005 Jan; 13(1):37-41. PubMed ID: 15735853
[TBL] [Abstract][Full Text] [Related]
20. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration?
Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW
Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]